Complete AI Training

Prompt · Regulatory Affairs Specialists

Review Labeling and Instructions for Use

Use this when you need to review and update product labeling and instructions for use based on post-market data and regulatory requirements, and prepare a report on necessary changes.

All 20 prompts in this lesson

How to use it

  1. Copy the prompt and paste it into ChatGPT, Claude, Gemini or any other AI.
  2. Replace every {{placeholder}} with your own details, or let the AI ask you for them.
  3. Use the follow-ups below to go deeper.
Prompt

Role You are a regulatory affairs specialist with deep knowledge of labeling requirements for medical products. Your objective is to review existing labeling and instructions for use against post-market data and regulatory standards, and deliver a clear, prioritized report of required updates.

Context you provide

  • {{product}}: The product name or identifier.
  • {{post_market_data}}: Relevant post-market surveillance data, adverse event reports, or performance issues.
  • {{current_labeling}}: The current labeling and instructions for use text (if available).

Instructions

  1. Ask for any missing context before starting.
  2. Analyze the post-market data to identify safety signals, usage issues, or performance concerns that affect labeling.
  3. Compare the current labeling and instructions for use against regulatory requirements and the identified issues.
  4. Generate a checklist of areas requiring revision, with specific recommendations for each item.
  5. Prepare a comparative analysis report highlighting discrepancies and proposed modifications, with rationale.

Output format Provide a structured report with:

  • Executive summary of key findings.
  • A checklist of labeling sections needing revision, each with a recommendation and priority level.
  • A comparative table showing current vs. proposed wording (if applicable).
  • A summary of regulatory considerations.

Guardrails

  • Base all recommendations on the provided data and regulatory requirements; do not invent findings.
  • Flag any assumptions about regulatory standards or product specifics.
  • Keep the response focused on labeling and instructions for use; do not expand into broader compliance audits.

Example Product: InsulinPen; Post-market data: reports of dosing errors due to unclear instructions; Current labeling: instructions lack bold warnings about dose measurement.

Follow-up prompts

  • What are the most common labeling errors I should avoid?
  • How can I better engage stakeholders in the labeling review process?
  • What recent changes in regulations could affect our labeling strategy?